Sascha Gerdes
Kiel, SH, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 154 publications
Switchback from biosimilar tumor necrosis factor-alpha inhibitors to reference medicines: a review.
Journal: Expert review of clinical immunology
Published: September 03, 2026
Clinical and molecular improvements in pediatric patients with atopic dermatitis treated with dupilumab: An analysis from the TREATKids registry.
Journal: The Journal of investigative dermatology
Published: March 26, 2026
Could the IL-17 cytokine family be a promising target for the treatment of palmoplantar pustulosis?
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: February 20, 2026
Durability of Response to Icotrokinra in Adults With Moderate-to-Severe Plaque Psoriasis: One-Year Results From the Phase 3, Placebo- and Active Comparator-Controlled ICONIC-ADVANCE 1 & ICONIC-ADVANCE 2 Trials.
Journal: The British journal of dermatology
Published: January 30, 2026
Paediatric psoriasis and biologics: An evidence gap in plain sight.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: January 08, 2026
Patient-Reported Well-Being in Value-Based Routine Care in Psoriatic Disease Using Tildrakizumab: 2-Year Data of the Phase IV POSITIVE Study.
Journal: Psoriasis (Auckland, N.Z.)
Published: January 05, 2026
S1 Guideline: Therapy of generalized pustular psoriasis.
Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Published: December 11, 2025
Large Eczema Area and Severity Index response at 2-year follow-up of patients treated with dupilumab in routine care of atopic dermatitis: results from the national registry TREATgermany.
Journal: Skin health and disease
Published: November 28, 2025
Case Report: Dupilumab in difficult-to-treat bullous pemphigoid at the University Hospital Schleswig-Holstein, Campus Kiel.
Journal: Frontiers in medicine
Published: September 01, 2025
Once-daily oral icotrokinra versus placebo and once-daily oral deucravacitinib in participants with moderate-to-severe plaque psoriasis (ICONIC-ADVANCE 1 & 2): two phase 3, randomised, placebo-controlled and active-comparator-controlled trials.
Journal: Lancet (London, England)
Published: July 08, 2025
A Global Assessment of Patient Experience and Quality of Life in Generalized Pustular Psoriasis: Results from Interviews and Online Surveys.
Journal: Dermatology and therapy
Published: May 02, 2025
Effects of a Gel Containing the Defined Microalgae Extract Spiralin® on the Skin Microbiome and Clinical Activity in Atopic Dermatitis: A Double-Blind, Intraindividual Vehicle-Controlled Proof-Of-Concept Study.
Journal: Skin pharmacology and physiology
Published: March 26, 2025
Last Updated: 09/26/2026